Organon (OGN) Stock Price Target 2026

The average analyst price target for Organon is $14.43, 4.6% above the current price. Of 5 analysts, 3 rate it Hold and 2 Sell. Targets range from $8 to $24. The latest change came on Apr 29, 2026, when BNP Paribas downgraded Organon from Outperform to Neutral and moved its price target from $12 to $14.

The Average Analyst Price Target for Organon is $14.43.

Price Target Range — 9 Quarters

Analyst Consensus — 5 Analysts

3Hold

2Sell

Consensus RatingNeutral# Analysts5Avg. Consensus PT$14.43Upside to Avg. PT+4.6%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Organon Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Apr 29, 2026	BNP Paribas	Navann Ty	Downgrade	Outperform→Neutral	$12→$14
Apr 28, 2026	Piper Sandler	David Amsellem	Upgrade	Underweight→Neutral	$5→$14
Feb 24, 2026	Barclays	Glen Santangelo	PT Raise	Underweight	$8→$8
Dec 9, 2025	Barclays	Glen Santangelo	Initiate	Underweight	$8
Nov 11, 2025	JP Morgan	Chris Schott	PT Cut	Underweight	$14→$12
Nov 11, 2025	Morgan Stanley	Terence Flynn	PT Cut	Equal-Weight	$10→$9
May 15, 2025	Piper Sandler	David Amsellem	PT Cut	Overweight	$24→$18
May 5, 2025	Morgan Stanley	Terence Flynn	PT Cut	Equal-Weight	$15→$10
Apr 9, 2025	Morgan Stanley	Terence Flynn	PT Cut	Equal-Weight	$16→$15
Feb 14, 2025	Barclays	Balaji Prasad	PT Cut	Overweight	$26→$24
Feb 14, 2025	Morgan Stanley	Terence Flynn	PT Cut	Equal-Weight	$17→$16
Sep 6, 2024	JP Morgan	Chris Schott	Downgrade	Neutral→Underweight	$18→$20
May 6, 2024	Goldman Sachs	Chris Shibutani	PT Raise	Neutral	$18→$20
May 3, 2024	Goldman Sachs	Chris Shibutani	PT Raise	Neutral	$18→$20
Apr 29, 2024	Piper Sandler	David Amsellem	PT Raise	Overweight	$22→$24
Feb 20, 2024	Goldman Sachs	Chris Shibutani	PT Raise	Neutral	$16→$18
Nov 22, 2023	Piper Sandler	David Amsellem	PT Cut	Overweight	$32→$22